top of page

BiotechTV visited South San Francisco based Noetik and saw how they are digitizing tumor samples and using AI to sort through the complexity of cancer biology for drug discovery

blonca9
4 hours ago
1 min read

Co-Founder and CEO Ron Alfa walked BiotechTV's Ryan Flinn through how machine learning is taking cancer cell biology beyond the microscope.

Recent Posts

Emeryville, CA based Profusa is developing an injectable biosensor that aims to generate biochemistry information for users in real time

Emeryville, CA based Profusa is developing an injectable biosensor that aims to generate biochemistry information for users in real time

Oxford's OrganOx became one of the UK's biggest news stories when it was announced it would be acquired by Japan's Terumo for approximately $1.5 billion - here's the revolutionary technology behind it

Oxford's OrganOx became one of the UK's biggest news stories when it was announced it would be acquired by Japan's Terumo for approximately $1.5 billion - here's the revolutionary technology behind it

Eko Health's Co-Founder & CEO shows BiotechTV the company's digital stethoscope, and explains how having both an electric and sound component can help physicians catch heart disease (and more) earlier

Eko Health's Co-Founder & CEO shows BiotechTV the company's digital stethoscope, and explains how having both an electric and sound component can help physicians catch heart disease (and more) earlier

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page